Les publications cls sont : Lau et al., Lancet 2021 (PMID 34798060) pour l'essai Phase 2 (n=706), l'essai REDEFINE 1 (NEJM 2025) pour la Phase 3, et Lau et al., J Med Chem 2021 pour le dveloppement molculaire
Marcio de Souza Duarte, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
2.8 Mass spectrometry conditions and analysis Mass spectrometry conditions and data analysis were performed as previously described (19, 20)
Ive been into fitness since I was 16
Carolina Schneider, MS, RD, nutrition advisor at Daily Harvest, says GLP-1 medications work by reducing appetite, so individuals on these medications must prioritize nutrient-dense foods to meet daily nutritional needs despite reduced food intake. Consuming the wrong types of food can not only reduce the effectiveness of the medication, but also exacerbate side effects